Hyi Jeong Ji

Executive Vice President & Head of Bio Research Institute, QA at Genexine, Inc.

Hyi Jeong Ji

Hyi Jeong Ji

Executive Vice President & Head of Bio Research Institute, QA at Genexine, Inc.

Overview
RelSci Relationships

29

Number of Boards

1

Relationships
RelSci Relationships are individuals Hyi Jeong Ji likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Genexine, Inc.

Relationship likelihood: Strong

President & Chief Operating Officer at Genexine, Inc.

Relationship likelihood: Strong

Chief Executive Officer, R&D at Genexine, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Managing Director at Genexine, Inc.

Relationship likelihood: Strong

Vice President & Head, Research Institute at Genexine, Inc.

Relationship likelihood: Strong

Executive Vice President, Deputy Director of Bio Research Institute at Genexine, Inc.

Relationship likelihood: Strong

Executive Vice President at Genexine, Inc.

Relationship likelihood: Strong

Managing Partner at Portola Capital Partners

Relationship likelihood: Strong

Director, Corporate Development & Transaction at Genexine, Inc.

Relationship likelihood: Strong

Former Director, Senior MD & Head-Development at Genexine, Inc.

Relationship likelihood: Strong

Paths to Hyi Jeong Ji
Potential Connections via
Relationship Science
You
Hyi Jeong Ji
Executive Vice President & Head of Bio Research Institute, QA at Genexine, Inc.
Career History
Executive Vice President & Head of Bio Research Institute, QA
Current

Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. It operates through the following business divisions: Novel drug development and Cell culture media manufacturing. The company was founded by Young Chul Sung on June 8, 1999 and is headquartered in Seongnam, South Korea.

Boards & Committees
Member, Board of Directors
Current

Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. It operates through the following business divisions: Novel drug development and Cell culture media manufacturing. The company was founded by Young Chul Sung on June 8, 1999 and is headquartered in Seongnam, South Korea.

Other Affiliations

Hyi Jeong Ji is affiliated with Genexine, Inc., Genexine, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hyi Jeong Ji. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hyi Jeong Ji's profile does not indicate a business or promotional relationship of any kind between RelSci and Hyi Jeong Ji.